Hydroxyzine Dosing Recommendations
For adults, hydroxyzine is typically dosed at 25 mg three to four times daily for pruritus/allergic conditions, or 50-100 mg four times daily for anxiety, with dose reductions required in renal and hepatic impairment; children under 6 years receive 50 mg total daily in divided doses, while children over 6 years receive 50-100 mg daily in divided doses. 1
Adult Dosing
Standard Indications
For pruritus and allergic conditions (chronic urticaria, atopic dermatitis, contact dermatoses):
For anxiety and tension associated with psychoneurosis:
- 50-100 mg four times daily 1
For preoperative sedation:
- 50-100 mg as a single dose 1
Important Caveat on Dosing Strategy
The guidelines emphasize that hydroxyzine works better as prophylactic rather than acute treatment because once histamine-mediated symptoms appear, it's too late to block histamine binding to receptors 3. This means regular scheduled dosing is more effective than as-needed use.
Pediatric Dosing
Children under 6 years:
- 50 mg total daily dose, divided (for both anxiety and pruritus indications) 1
Children over 6 years:
- 50-100 mg total daily dose, divided 1
Preoperative sedation in children:
- 0.6 mg/kg body weight 1
Pediatric Safety Concern
A 2021 population study found that repeat prescriptions of hydroxyzine in preschool children were associated with increased rates of tics, anxiety, and conduct disturbances (odds ratios 1.34-1.55) 4. This suggests using the shortest possible duration in children under 5 years 4.
Elderly Patients
Critical consideration: First-generation H1 blockers like hydroxyzine with anticholinergic effects are associated with cognitive decline, especially in elderly populations 3. The guidelines note concerns about reduced concentration, performance impairment, and driving ability 2.
Practical approach for elderly:
- Consider non-sedating second-generation antihistamines first (cetirizine, fexofenadine, loratadine)
- If hydroxyzine is necessary, start at lower end of dosing range (e.g., 10-25 mg at bedtime)
- Monitor closely for sedation and cognitive effects
Renal Impairment
Moderate renal impairment (creatinine clearance 10-20 mL/min):
- Reduce hydroxyzine dose by 50% 2
Severe renal impairment (creatinine clearance <10 mL/min):
- Avoid hydroxyzine 2
Hepatic Impairment
Severe liver disease:
- Avoid hydroxyzine entirely because its sedating effect is inappropriate and may precipitate hepatic encephalopathy 2
Primary biliary cirrhosis data: A pharmacokinetic study showed hydroxyzine elimination half-life is dramatically prolonged to 36.6 hours (vs. normal ~20 hours) in patients with primary biliary cirrhosis, with clearance reduced to 8.65 mL/min/kg 5. One patient in a cirrhosis study developed acute encephalopathy that reversed upon stopping hydroxyzine 6.
Practical guidance: In any hepatic dysfunction, avoid hydroxyzine or use extreme caution with significantly reduced doses (consider 25% to 50% of normal dose) and monitor closely for encephalopathy.
Special Populations
Pregnancy
Hydroxyzine is specifically contraindicated in early pregnancy according to U.K. manufacturer guidelines 2. It is the only antihistamine with this specific contraindication. Avoid in all trimesters, particularly first trimester 2.
Lactation
Avoid during breastfeeding 2
Clinical Pearls
Sedation profile: Unlike diphenhydramine, hydroxyzine poisoning causes more CNS depression and fewer antimuscarinic effects (less delirium, fewer anticholinergic findings) 7. This means expect sedation as the primary side effect rather than classic anticholinergic toxidrome.
Timing considerations: When used for sleep, administer 25-50 mg at bedtime 8, 6. Studies show mixed efficacy for insomnia, suggesting it should be considered only when other options have failed 8.
Cardiovascular caution: The 2019 MCAS guidelines express concern about using first-generation antihistamines like hydroxyzine in patients prone to cardiovascular events 3.
Dose adjustment principle: The FDA label states "dosage should be adjusted according to the patient's response to therapy" 1, but given the safety concerns in elderly and hepatically impaired patients, err on the side of lower doses in these populations.